3200 Lakeside Dr.
Santa Clara
CA
95054
USA
(408) 845-3000
Related Content
March 15, 2012 โ According to Millennium Research Group (MRG) the interventional cardiology (IC) market in Pakistan ...
March 15, 2012
Feature | Vascular Closure Devices| Dave Fornell
Manual compression remains the gold standard of care in sealing interventional access site wounds, but there is a trend ...
February 01, 2012
December 22, 2011 ยญโ Abbott today announced the initiation of ESPRIT I, a first-of-its-kind clinical trial in Europe ...
December 22, 2011
December 9, 2011 โ Abbott announced Thursday the initiation of ABSORB II, the first randomized, controlled, multi-center ...
December 09, 2011
November 15, 2011 โ Abbott announced positive long-term data from the two-stage ABSORB trial, which is evaluating the ...
November 15, 2011
November 14, 2011 โ The TWENTE clinical trial, which compared Resolute versus Xience V drug-eluting stents in a real ...
November 14, 2011
MitraClip Offers Significant Improvements for Both Functional, Degenerative MR in High-Risk Patients
November 10, 2011 โ The results of an analysis of 149 EVEREST II high surgical risk patients with significant mitral ...
November 10, 2011
November 8, 2011 โ Abiomed, a provider of heart support technologies, announced results of an economic study at the ...
November 08, 2011
November 7, 2011 โ Abbott announced the company's schedule of key data presentations at the 23rd annual Transcatheter ...
November 07, 2011
Nov. 2, 2011 โ The U.S. Food and Drug Administration (FDA) granted market clearance for the Xience Prime everolimus ...
November 02, 2011ยฉ Copyright Wainscot Media. All Rights Reserved.
Subscribe Now